Medication Maintenance Therapy in Community Pharmacy Settings
Completed · Early Phase 1
Conditions studied: Opioid-use Disorder
In brief
The goal of this study is to examine how the pharmacy can better optimize treatment expansion by providing pharmacy-based medication assisted treatment (MAT) for maintenance under a collaborative pharmacy practice agreement.
Key facts
- Study ID
- NCT03766893
- Run by
- Lifespan
- People needed
- 11
- Starts
- 2018-09-01
- Expected to finish
- 2018-12-31
- Last updated by the study team
- 2019-08-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- 18 years of age or older;
- English speaking; currently enrolled at a CODAC site in Rhode Island for the treatment of opioid use disorder;
- maintained on a stable dose of buprenorphine or injectable naltrexone for at least 2 days;
- no stable co-morbid illnesses likely to progress clinically during the pilot study;
- able and willing to provide written informed consent and locator information (working telephone and >2 contacts) to participate.
You may not qualify if…
- currently pregnant or trying to get pregnant;
- plans to move or leave the state during the study, including pending legal action;
- self reported past year suicide attempt or self-reported past year suicidal thoughts with a plan;
- any condition that, in the researchers' judgment, interferes with safe study participation or adherence to study procedures, including but not limited to a mental, medical or other substance use disorder that is likely to require ongoing, intense clinical management during the pilot study.
Where it is running
- Rhode Island Hospital — Providence, Rhode Island, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.